切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2020, Vol. 15 ›› Issue (02) : 128 -132. doi: 10.3877/cma.j.issn.1673-9450.2020.02.009

所属专题: 文献

论著

术前他汀类药物治疗对冠状动脉旁路移植术后胸骨切口感染事件和主要心脑血管不良事件发生的影响
王家阳1,(), 张魁1, 董然1, 王健2   
  1. 1. 100029 首都医科大学附属北京安贞医院心脏外科
    2. 150040 哈尔滨市第五医院院长办公室
  • 收稿日期:2020-02-10 出版日期:2020-04-01
  • 通信作者: 王家阳
  • 基金资助:
    国家自然科学基金青年项目(81900098)

Effect of preoperative statin therapy on the incidence of sternum incision infection and major cardiovascular and cerebrovascular adverse events after coronary artery bypass grafting

Jiayang Wang1,(), Kui Zhang1, Ran Dong1, Jian Wang2   

  1. 1. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
    2. Director Office, Fifth Hospital in Harbin, 150040 Harbin, China
  • Received:2020-02-10 Published:2020-04-01
  • Corresponding author: Jiayang Wang
  • About author:
    Corresponding author: Wang Jiayang, Email:
引用本文:

王家阳, 张魁, 董然, 王健. 术前他汀类药物治疗对冠状动脉旁路移植术后胸骨切口感染事件和主要心脑血管不良事件发生的影响[J/OL]. 中华损伤与修复杂志(电子版), 2020, 15(02): 128-132.

Jiayang Wang, Kui Zhang, Ran Dong, Jian Wang. Effect of preoperative statin therapy on the incidence of sternum incision infection and major cardiovascular and cerebrovascular adverse events after coronary artery bypass grafting[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2020, 15(02): 128-132.

目的

探讨冠状动脉旁路移植术(CABG)术前应用他汀类药物干预对患者术后胸骨切口感染事件发生率和主要心脑血管不良事件发生情况的影响。

方法

选择2019年1月至12月于首都医科大学附属北京安贞医院心外科住院并行CABG治疗的患者880例。503例(57.2%)患者在CABG术前接受过他汀类药物治疗,将这些患者设为试验组;其余377例患者术前未应用他汀类药物,设为对照组。比较试验组和对照组患者的胸骨切口感染事件和主要心脑血管不良事件发生情况,再进行相应的风险因素分析。数据比较采用χ2检验、单因素方差分析和多元逻辑回归分析。

结果

试验组患者CABG术后胸骨切口感染事件的发生率、主要心脑血管不良事件的发生率分别为2.0%、27.6%,与对照组(5.6%、35.0%)比较,差异均有统计学意义(χ2=0.869、0.298,P=0.005、0.022)。同时多元逻辑回归结果显示患者CABG术前应用他汀类药物治疗与术后胸骨切口感染事件显著下降具有独立相关性(OR 0.34,95%CI 0.16~0.74,P=0.006)。此外,术前应用他汀类药物干预也与CABG术后主要心脑血管不良事件的发生率降低独立有关(OR 0.60,95% CI 0.44~0.81,P=0.001)。

结论

术前应用他汀类药物治疗能够降低患者CABG术后胸骨切口感染事件和主要心脑血管不良事件的发生。

Objective

To investigate the independent relationship between preoperative statin therapy and postoperative sternal wound infection major cardiovascular and cerebrovascular adverse events in patients undergoing coronary artery bypass grafting(CABG).

Methods

A toal of 880 patients undergoing CABG were enrolled from January 1, 2019 to December 31, 2019 in Beijing Anzhen Hospital, Capital Medical University. Five hundred and three patients (57.2%) who received statins before CABG were assigned to the experimental group. The remaining 377 patients were not treated with statins before surgery and were set as the control group. The incidence of sternal incision infection and major cardiovascular and cerebrovascular adverse events in the experimental group and the control group were compared, and the corresponding risk factors were analyzed. Data were compared with chi-square test, single factor analysis of variance and multivariate logistic regression analysis.

Results

The incidence of sternal incision infection and the incidence of major cardiovascular and cerebrovascular adverse events were 2.0% and 27.6%, respectively, compared with the experimental group (5.6% and 35.0%), the differences were statistically significant (χ2=0.869, 0.298; P=0.005, 0.022). Specifically, preoperative statin therapy independently reduced the incidence of sternal wound infection after CABG (OR 0.34, 95%CI 0.16-0.74; P=0.006) and major cardiovascular and cerebrovascular adverse events (OR 0.60, 95% CI 0.44-0.91; P=0.001).

Conclusion

Preoperative statin therapy is effective in deep sternal wound infection and major cardiovascular events among high-risk patients undergoing CABG.

表1 2组行CABG治疗的患者的一般资料比较
表2 2组患者CABG术后终点事件对比[例(%)]
表3 2组患者CABG术后心脑血管不良事件的具体对比[例(%)]
表4 影响患者CABG术后胸骨切口感染事件发生率的风险因素分析
表5 影响患者CABG术后主要心脑血管不良事件的独立风险因素
[1]
胡盛寿,高润霖,刘力生,等. 《中国心血管病报告2018》概要[J]. 中国循环杂志,2019, 34(3): 209-220.
[2]
刘冬,王文璋,蔡爱兵,等. 心脏手术后深部胸骨切口感染修复与重建189例临床分析[J]. 中华外科杂志,2015, 523(3): 193-196.
[3]
Wang J, Yu W, Zhao D, et al. In-Hospital and Long-Term Mortality in 35,173 Chinese Patients Undergoing Coronary Artery Bypass Grafting in Beijing: Impact of Sex, Age, Myocardial Infarction, and Cardiopulmonary Bypass[J]. J Cardiothorac Vasc Anesth, 2017, 31(1): 26-31.
[4]
Stanifer BP, Andrei AC, Liu M, et al. Short Term Outcomes of Tracheal Resection in the Society of Thoracic Surgeons Database[J]. Ann Thorac Surg, 2018, 106(6): 1612-1618.
[5]
Jones SP, Lefer DJ. Cardioprotective actions of acute HMG-CoA reductase inhibition in the setting of myocardial infarction[J]. Acta Physiol Scand, 2001, 173(1): 139-143.
[6]
Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis[J]. Circulation, 2004, 110(7): 880-885.
[7]
Gupta R, Plantinga LC, Fink NE, et al. Statin use and sepsis events [corrected] in patients with chronic kidney disease[J]. JAMA, 2007, 297(13): 1455-1464.
[8]
Hackam DG, Mamdani M, Li P, et al. Statins and sepsis in patients with cardiovascular disease: a populationbased cohort analysis[J]. Lancet, 2006, 367(9508): 413-418.
[9]
Coleman CI, Lucek DM, Hammond J, et al. Preoperative statins and infectious complications following cardiac surgery[J]. Curr Med Res Opin, 2007, 23(8): 1783-1790.
[10]
张翔,孙成超. 家兔体外循环停跳动物模型的建立[J]. 温州医学院学报,2007, 37(3): 221-223.
[11]
Terblanche M, Almog Y, Rosenson RS, et al. Statins: panacea for sepsis[J]. Lancet Infect Dis, 2006, 6(4): 242-248.
[12]
杨华摇,刘海平,汪虹,等. 他汀类药物促进血管新生及在创面修复们中的意义[J/CD]. 中华损伤与修复杂志(电子版), 2010, 5(6): 803-806.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 李小飞, 刘洪莉, 石丘玲, 田静, 李莉, 漆洪波, 罗欣. 自然分娩产妇低强度聚焦超声子宫复旧治疗防治产后出血的前瞻性随机对照研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 534-539.
[3] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[4] 刘欢, 邢皓, 常正奇, 张记. 机械敏感性离子通道蛋白Piezo1在感染相关疾病中的研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 263-269.
[5] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[6] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[7] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[8] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[9] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[10] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[11] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[12] 胡菊英, 李银华, 洪兰, 王宏勇, 丁先军, 李承美, 谭心海. 儿童感染大叶性肺炎与支气管肺炎临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 813-816.
[13] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[14] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[15] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
阅读次数
全文


摘要